Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;10(3):294-9.
doi: 10.4306/pi.2013.10.3.294. Epub 2013 Sep 16.

Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder

Jae-Won Kim  1 , Yong-Ku Kim, Jung-A Hwang, Ho-Kyoung Yoon, Young-Hoon Ko, Changsu Han, Heon-Jeong Lee, Byung-Joo Ham, Hong Seock Lee
Affiliations

Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder

Jae-Won Kim et al. Psychiatry Investig. 2013 Sep.

Abstract

Objective: Cytokines are believed to have a role in the pathophysiology of major depression. The alteration in levels of pro-inflammatory cytokines [interleukin 1β (IL-1β), IL-2, IL-6, IL-12, interferon γ, and tumor necrosis factor α] in major depression supports the cytokine hypothesis of this illness. IL-23 and IL-17 are also pro-inflammatory cytokines, but few studies have focused on their role in major depression. This study investigated the potential role of the IL-23 and IL-17 axis in major depression.

Methods: Plasma IL-23 and IL-17 levels were measured in 26 major depressive disorder (MDD) patients before and after 6-week treatment with antidepressants; these levels were measured in 28 age- and sex-matched normal controls. Depression severity was assessed using the Hamilton Depression Rating Scale (HDRS). IL-23 and IL-17 plasma levels were estimated using quantitative enzyme-linked immunosorbent assay.

Results: Pre-treatment plasma levels of IL-23 and IL-17 in MDD patients were not significantly different from those of normal controls. In MDD patients, IL-23 and IL-17 levels after 6 weeks of antidepressant treatment were not different from the baseline levels. There was no significant correlation between changes in the cytokine levels and changes in the HDRS scores representing the severity of depression.

Conclusion: The present study does not support a potential involvement of IL-23 and IL-17 axis in major depression. Replication and extension using a larger sample are required.

Keywords: Cytokine; IL-17; IL-23; Immune; Major depressive disorder; Th17 cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of the baseline cytokine levels between normal controls and MDD patients. MDD: major depressive disorder.
Figure 2
Figure 2
Comparison of cytokine levels in MDD patients at baseline and 6 weeks after antidepressant treatment. MDD: major depressive disorder.
See this image and copyright information in PMC

References

    1. Dubas-Slemp H, Marmurowska-Michalowska H, Szuster-Ciesielska A, Kaminska T, Kandefer-Szerszen M. The role of cytokines in depression. Psychiatr Pol. 2003;37:787–798. - PubMed
    1. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:201–217. - PubMed
    1. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374–383. - PubMed
    1. Munoz-Fernandez MA, Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998;56:307–340. - PubMed
    1. Szelenyi J. Cytokines and the central nervous system. Brain Res Bull. 2001;54:329–338. - PubMed

LinkOut - more resources